H. Lundbeck AS (LTS:0ABR) Total Tax Payable: kr258 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0ABR H. Lundbeck AS LTS:0ABR
78 GF Score
Price kr35.58
GF Value kr38.20
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is H. Lundbeck AS Total Tax Payable?

H. Lundbeck AS LTS:0ABR -0.77% 78 Total Tax Payable is kr258 Mil as of Mar. 2026. GuruFocus rates LTS:0ABR with a GF Score™ of 78/100 and a GF Value™ of kr38.20 (Fairly Valued). The stock has 3 warning signs investors should review.

H. Lundbeck AS's Total Tax Payable for the quarter that ended in Mar. 2026 was kr258 Mil.

H. Lundbeck AS's quarterly Total Tax Payable declined from Sep. 2025 (kr947 Mil) to Dec. 2025 (kr693 Mil) and declined from Dec. 2025 (kr693 Mil) to Mar. 2026 (kr258 Mil).

H. Lundbeck AS's annual Total Tax Payable declined from Dec. 2023 (kr571 Mil) to Dec. 2024 (kr316 Mil) but then increased from Dec. 2024 (kr316 Mil) to Dec. 2025 (kr693 Mil).

H. Lundbeck AS Total Tax Payable Related Terms

H. Lundbeck AS Total Tax Payable Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Total Tax Payable Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 519.00 535.00 571.00 316.00 693.00

H. Lundbeck AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 190.00 284.00 947.00 693.00 258.00
LTS:0ABR
78GF Score
H. Lundbeck AS LTS:0ABR
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of kr258 Mil mean?
H. Lundbeck AS (LTS:0ABR) has a Total Tax Payable of kr258 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on H. Lundbeck AS and its competitors.
Is H. Lundbeck AS's Total Tax Payable too high?
H. Lundbeck AS's current Total Tax Payable is kr258 Mil. Overall, H. Lundbeck AS has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's Total Tax Payable compare to ZTS and UTHR?
H. Lundbeck AS's Total Tax Payable of kr258 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on H. Lundbeck AS and its competitors. H. Lundbeck AS's current Total Tax Payable is kr258 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (LTS:0ABR) is currently considered Fairly Valued. The stock's GF Value™ is kr38.20, compared to a current price of kr35.58 — trading 6.9% below its estimated fair value. The current Total Tax Payable is kr258 Mil. H. Lundbeck AS's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For H. Lundbeck AS (LTS:0ABR), the current Total Tax Payable is kr258 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H. Lundbeck AS (LTS:0ABR) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of kr35.58 is trading 6.9% below its estimated GF Value™ of kr38.20. GuruFocus considers H. Lundbeck AS to be Fairly Valued.

Key valuation signals for LTS:0ABR:

  • Total Tax Payable: kr258 Mil
  • GF Value™: kr38.20 vs. price of kr35.58 (6.9% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the LTS:0ABR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
78GF Score

Get the complete analysis for LTS:0ABR

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.58
Price
kr38.20
GF Value